drugset
drugset / Trial / NCT03310970

Pharmacokinetics of Lidocaine in Healthy Adults

NCT03310970 ↗

Phase 4 Completed 23 enrolled Nicole K Brogden Long Island University · collab
Non-randomizedCrossoverOpen-labelBasic science

Summary

The study to be performed will utilize already FDA-approved marketed products in healthy adults for the purpose to generate data for establishing rate of drug delivery of Lidoderm® topical patch (manufactured by Endo Pharmaceuticals) and the lidocaine 5% patch (manufactured by Mylan Pharmaceuticals) in healthy adults, and to ensure the safety of individuals utilizing these types of products.

Timeline

Start
2018-03-14
Primary completion
2019-10-09
Completion
2019-10-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 0.5 mg/kg Topical
Comparator Lidocaine Other / unclassified 5 % Topical

Indications

No indication recorded.